Genomines
PrivateLast Round
Series A
Sep 17, 2025
Total Funding Raised
$75.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genomines is a biotechnology company that provides plant-based mining services for sustainable metal extraction using genetically enhanced hyperaccumulator plants.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Circular Economy, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomines Comparables
Compare Genomines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PhytoMines | 84% | |
| Botanickel | 84% | |
| Econick | 82% |
Genomines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 17, 2025 | ||||
| Grant | Jan 11, 2022 | ||||
| Grant | Jan 11, 2022 | ||||
| Seed | Oct 22, 2021 | ||||
| Seed | Aug 1, 2021 |
Key People
Founding team and executive leadership
Genomines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Engine Ventures | Series A |
| Forbion | Series A |
| Elemental Impact | Series A |
| DeepTech & Climate Fonds | Series A |
| RAISE Sherpas | Series A |
| Lowercarbon Capital | Series A, Seed |
| Engine Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 91% MoM, reaching 3.4K.
- Apr 1, 2026
Aidan D. promoted to Chief of Staff from internship.
Genomines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genomines's valuation, stock price, and market status.
Is Genomines a public or private company?
Genomines is a private company.
What is the current stock price of Genomines?
Genomines is a private company with no public stock price. No recent secondary market data is available.
How much is Genomines worth (valuation)?
Valuation information for Genomines is not publicly available.
Can I buy Genomines stock?
Genomines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genomines's last funding round?
Genomines's most recent funding round was Series A on September 17, 2025.
Who are the main investors in Genomines?
Key investors in Genomines include Engine Ventures, Forbion, Lowercarbon Capital, Engine Ventures.
Will Genomines IPO soon?
No public IPO plans have been announced for Genomines.
How can I track Genomines secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genomines's secondary market activity and sign up for updates.